ID
41202
Beschrijving
A Study of MabThera (Rituximab) in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia And Favorable Somatic Status; ODM derived from: https://clinicaltrials.gov/show/NCT01271010
Link
https://clinicaltrials.gov/show/NCT01271010
Trefwoorden
Versies (1)
- 12-07-20 12-07-20 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
12 juli 2020
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Lymphocytic Leukemia, Chronic NCT01271010
Eligibility Lymphocytic Leukemia, Chronic NCT01271010
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Small Cell Lymphoma
Datatype
boolean
Alias
- UMLS CUI [1]
- C0024303
Beschrijving
Autoimmune hemolytic anemia
Datatype
boolean
Alias
- UMLS CUI [1]
- C0002880
Beschrijving
Cancer Other | Exception Basal cell carcinoma
Datatype
boolean
Alias
- UMLS CUI [1]
- C1707251
- UMLS CUI [2,1]
- C1705847
- UMLS CUI [2,2]
- C0007117
Beschrijving
Chemotherapy Comorbidity
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0392920
- UMLS CUI [1,2]
- C0009488
Beschrijving
Richter's syndrome
Datatype
boolean
Alias
- UMLS CUI [1]
- C0349631
Similar models
Eligibility Lymphocytic Leukemia, Chronic NCT01271010
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C0332155 (UMLS CUI [1,2])
C4525403 (UMLS CUI [2])
C0242656 (UMLS CUI [2])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C0009488 (UMLS CUI [1,2])
Geen commentaren